Can the systemic immune inflammation index be a predictor of BCG response in patients with high-risk non-muscle invasive bladder cancer?

Serkan Akan Caner Ediz Aytac Sahin Hasan Huseyin Tavukcu Ahmet Urkmez Alper Horasan Ömer Yilmaz Ayhan Verit

Published in: International journal of clinical practice (2020)

The SII might be a successful, non-invasive and low-cost parameter for prediction of BCG failure in patients with high-risk NMIBC. The cut-off value for SII is 672.75 and above this level BCG failure and progression to MIBC might be anticipated. However, these results should be validated in prospective randomised controlled studies with large patient groups.

Keyphrases

muscle invasive bladder cancer
low cost
oxidative stress
study protocol
drug induced